Modular Medical, Inc. announced today, September 30 2025, that it has exercised a block of existing warrants issued in May 2023 and March 2025. The exercise was conducted at a reduced price of $0.68 per share and generated $4.4 million in gross proceeds.
The warrants are registered under effective Form S‑1 registration statements, and the shares issuable upon exercise are common stock. The exercise price reflects a significant discount to the warrants’ original terms, underscoring the company’s effort to secure additional capital at a favorable cost.
This financing event provides Modular Medical with additional liquidity to fund ongoing product development, regulatory submissions, and the planned commercial launch of its MODD1 pump. The infusion of capital is a material development for investors, as it extends the company’s runway and supports its strategy to capture the “almost‑pumper” segment of the diabetes market.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.